10.1016/j.dsx.2020.03.008 [DOI] [PubMed] [Google Scholar] 11.Asbaghi O, Moradi S, Kashkooli S, Zobeiri M, Nezamoleslami S, Lazaridi A-V, et al
Mochi Health Mochi Health provides virtual weight management programs with physician oversight and ongoing follow-up appointments
Apathy in early and late-life depression
The most common gastrointestinal side effects include: Nausea : Reported in 15-44% of patients (higher rates at Wegovy 2.4 mg), typically most pronounced during dose escalation Diarrhea : Affects approximately 8-30% of users, ranging from mild to moderate severity Vomiting : Occurs in 5-24% of patients (higher rates at Wegovy 2.4 mg), often associated with rapid dose increases Abdominal pain : Experienced by 5-20% of patients, usually described as cramping or discomfort Constipation : Paradoxically affects 3-24% despite the medication's effects on motility Dyspepsia and gastroesophageal reflux : Related to delayed gastric emptying These effects result from semaglutide's pharmacologic action on GLP-1 receptors throughout the gastrointestinal tract
Globalization of Industry-Sponsored, Clinical Trials
